Combining High-Throughput Synthesis and High-Throughput Protein Crystallography for Accelerated Hit Identification.
Acrylamides
/ chemical synthesis
Acrylates
/ chemical synthesis
Catalytic Domain
Coronavirus 3C Proteases
/ antagonists & inhibitors
Crystallography, X-Ray
Cysteine Proteinase Inhibitors
/ chemical synthesis
Drug Discovery
High-Throughput Screening Assays
Protein Binding
SARS-CoV-2
/ chemistry
Small Molecule Libraries
/ chemical synthesis
SARS-CoV-2
covalent inhibitors
high-throughput protein crystallography
multicomponent reactions
nanosynthesis
Journal
Angewandte Chemie (International ed. in English)
ISSN: 1521-3773
Titre abrégé: Angew Chem Int Ed Engl
Pays: Germany
ID NLM: 0370543
Informations de publication
Date de publication:
09 08 2021
09 08 2021
Historique:
revised:
31
05
2021
received:
24
04
2021
pubmed:
8
6
2021
medline:
12
8
2021
entrez:
7
6
2021
Statut:
ppublish
Résumé
Protein crystallography (PX) is widely used to drive advanced stages of drug optimization or to discover medicinal chemistry starting points by fragment soaking. However, recent progress in PX could allow for a more integrated role into early drug discovery. Here, we demonstrate for the first time the interplay of high throughput synthesis and high throughput PX. We describe a practical multicomponent reaction approach to acrylamides and -esters from diverse building blocks suitable for mmol scale synthesis on 96-well format and on a high-throughput nanoscale format in a highly automated fashion. High-throughput PX of our libraries efficiently yielded potent covalent inhibitors of the main protease of the COVID-19 causing agent, SARS-CoV-2. Our results demonstrate, that the marriage of in situ HT synthesis of (covalent) libraires and HT PX has the potential to accelerate hit finding and to provide meaningful strategies for medicinal chemistry projects.
Identifiants
pubmed: 34097796
doi: 10.1002/anie.202105584
pmc: PMC8456925
doi:
Substances chimiques
Acrylamides
0
Acrylates
0
Cysteine Proteinase Inhibitors
0
Small Molecule Libraries
0
3C-like proteinase, SARS-CoV-2
EC 3.4.22.-
Coronavirus 3C Proteases
EC 3.4.22.28
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
18231-18239Subventions
Organisme : the European Lead Factory (IMI)
ID : 115489
Organisme : COFUND ALERT
ID : 665250
Organisme : the Qatar National Research Foundation
ID : NPRP6-065-3-012
Organisme : National Institute of Health (NIH)
ID : 2R01GM097082-05
Organisme : NIGMS NIH HHS
ID : R01 GM097082
Pays : United States
Organisme : KWF Kankerbestrijding
ID : 10504
Organisme : ITN "Accelerated Early stage drug dIScovery"
ID : 675555
Organisme : the Swiss National Science Foundation
ID : 4078P0_198290
Informations de copyright
© 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.
Références
Nat Commun. 2017 Apr 24;8:15123
pubmed: 28436492
Org Lett. 2013 Feb 1;15(3):639-41
pubmed: 23331054
Science. 2020 Apr 24;368(6489):409-412
pubmed: 32198291
J Appl Crystallogr. 2020 Mar 25;53(Pt 2):477-485
pubmed: 32280322
RSC Med Chem. 2020 Dec 21;12(3):370-379
pubmed: 34041486
J Med Chem. 2020 Jul 9;63(13):6679-6693
pubmed: 32250617
Chem Rev. 2012 Jun 13;112(6):3083-135
pubmed: 22435608
Sci Adv. 2021 Feb 3;7(6):
pubmed: 33536213
J Med Chem. 2020 Jul 9;63(13):6863-6875
pubmed: 32529824
Drug Discov Today. 2018 Mar;23(3):727-735
pubmed: 29337202
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Acta Crystallogr D Struct Biol. 2020 Aug 1;76(Pt 8):771-777
pubmed: 32744259
J Med Chem. 2020 Jul 23;63(14):7559-7568
pubmed: 32543856
Angew Chem Int Ed Engl. 2021 Aug 9;60(33):18231-18239
pubmed: 34097796
Chem Biol. 2004 Oct;11(10):1445-53
pubmed: 15489171
Structure. 2020 Jun 2;28(6):694-706.e5
pubmed: 32413289
FEBS J. 2021 Sep;288(17):5089-5121
pubmed: 33400393
Angew Chem Int Ed Engl. 2020 Jul 20;59(30):12423-12427
pubmed: 32048418
Acta Crystallogr D Struct Biol. 2017 Mar 1;73(Pt 3):246-255
pubmed: 28291760
Protein Sci. 2020 Jan;29(1):52-65
pubmed: 31531901
J Org Chem. 2009 Sep 18;74(18):7084-93
pubmed: 19705810
Science. 2018 Jan 26;359(6374):429-434
pubmed: 29371464
Molecules. 2020 Feb 25;25(5):
pubmed: 32106588
Acc Chem Res. 2017 Dec 19;50(12):2976-2985
pubmed: 29172435
Sci Adv. 2021 Apr 14;7(16):
pubmed: 33853786
ChemMedChem. 2019 May 6;14(9):889-906
pubmed: 30816012
J Synchrotron Radiat. 2009 May;16(Pt 3):368-75
pubmed: 19395800
Nature. 2018 May;557(7704):228-232
pubmed: 29686415
Philos Trans A Math Phys Eng Sci. 2019 Jun 17;377(2147):20180422
pubmed: 31030650
Science. 2015 Jan 2;347(6217):49-53
pubmed: 25554781
Chem Soc Rev. 2004 Oct 20;33(8):558-65
pubmed: 15480479
Struct Dyn. 2017 Feb 28;4(3):032104
pubmed: 28345007
Chem Rev. 2006 Jan;106(1):17-89
pubmed: 16402771
Nat Rev Drug Discov. 2002 Jan;1(1):45-54
pubmed: 12119609
IUCrJ. 2015 Feb 03;2(Pt 2):246-55
pubmed: 25866661
Green Chem. 2019 Jan 21;21(2):225-232
pubmed: 30686932
ACS Cent Sci. 2019 Mar 27;5(3):451-457
pubmed: 30937372
Chem. 2020 Jun 11;6(6):1283-1295
pubmed: 32529116
Science. 2021 May 7;372(6542):642-646
pubmed: 33811162
Sci Adv. 2019 Jul 05;5(7):eaaw4607
pubmed: 31281893
Nat Commun. 2020 Oct 7;11(1):5047
pubmed: 33028810
Chem Rev. 2019 Feb 13;119(3):1970-2042
pubmed: 30707567
Acta Crystallogr D Struct Biol. 2021 Jan 1;77(Pt 1):62-74
pubmed: 33404526